DE69509673T2 - Peptide zur behandlung von allergien - Google Patents

Peptide zur behandlung von allergien

Info

Publication number
DE69509673T2
DE69509673T2 DE69509673T DE69509673T DE69509673T2 DE 69509673 T2 DE69509673 T2 DE 69509673T2 DE 69509673 T DE69509673 T DE 69509673T DE 69509673 T DE69509673 T DE 69509673T DE 69509673 T2 DE69509673 T2 DE 69509673T2
Authority
DE
Germany
Prior art keywords
pct
peptides
date
terminus
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69509673T
Other languages
English (en)
Other versions
DE69509673D1 (de
Inventor
Denis Stanworth
Ian Lewin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Holding Ltd
Original Assignee
Acambis Research Ltd
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acambis Research Ltd, Peptide Therapeutics Ltd filed Critical Acambis Research Ltd
Application granted granted Critical
Publication of DE69509673D1 publication Critical patent/DE69509673D1/de
Publication of DE69509673T2 publication Critical patent/DE69509673T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69509673T 1994-11-04 1995-11-03 Peptide zur behandlung von allergien Expired - Fee Related DE69509673T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422294A GB9422294D0 (en) 1994-11-04 1994-11-04 Peptides for anti-allergy treatment
PCT/GB1995/002580 WO1996014333A1 (en) 1994-11-04 1995-11-03 Peptides for anti-allergy treatment

Publications (2)

Publication Number Publication Date
DE69509673D1 DE69509673D1 (de) 1999-06-17
DE69509673T2 true DE69509673T2 (de) 2000-01-13

Family

ID=10763914

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69509673T Expired - Fee Related DE69509673T2 (de) 1994-11-04 1995-11-03 Peptide zur behandlung von allergien

Country Status (12)

Country Link
US (1) US5945104A (de)
EP (1) EP0789710B1 (de)
JP (1) JPH10509700A (de)
AT (1) ATE179989T1 (de)
AU (1) AU707483B2 (de)
CA (1) CA2204256A1 (de)
DE (1) DE69509673T2 (de)
DK (1) DK0789710T3 (de)
ES (1) ES2131339T3 (de)
GB (1) GB9422294D0 (de)
GR (1) GR3030777T3 (de)
WO (1) WO1996014333A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822763D0 (en) * 1998-10-20 1998-12-16 Univ Sheffield Immunoglobin variant
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2861593D1 (en) * 1977-06-29 1982-03-11 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
EP0288965A2 (de) * 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
EP0378881B1 (de) * 1989-01-17 1993-06-09 ENIRICERCHE S.p.A. Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JP3329868B2 (ja) * 1992-09-30 2002-09-30 株式会社クラレ ペプチドおよびこれを担体上に固定化してなる吸着剤
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
WO1994018345A1 (en) * 1993-02-05 1994-08-18 Affymax Technologies N.V. Receptor-binding antiproliferative peptides
GB9320897D0 (en) * 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
JP3504963B2 (ja) * 1993-10-22 2004-03-08 智靖 羅 抗ヒト高親和性ＩｇＥ受容体モノクローナル抗体に係るアミノ酸配列をコードするＤＮＡ断片

Also Published As

Publication number Publication date
GB9422294D0 (en) 1994-12-21
ATE179989T1 (de) 1999-05-15
AU3811195A (en) 1996-05-31
DK0789710T3 (da) 1999-11-01
AU707483B2 (en) 1999-07-08
WO1996014333A1 (en) 1996-05-17
US5945104A (en) 1999-08-31
DE69509673D1 (de) 1999-06-17
JPH10509700A (ja) 1998-09-22
GR3030777T3 (en) 1999-11-30
CA2204256A1 (en) 1996-05-17
ES2131339T3 (es) 1999-07-16
EP0789710A1 (de) 1997-08-20
EP0789710B1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
DE69535314D1 (de) Modifizierte pflanzenviren als vektore für heterologe peptide
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DE69839529D1 (de) Expressionsvektoren und zellinien zur expression von vaskulärem wachstumsfaktor d, sowie verfahren zur behandlung von melanomen
HK1014191A1 (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
DE69326064T2 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
DE3787842D1 (de) Mittel zur Behandlung von Arthrosen.
ATE230417T1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
DE69518760D1 (de) Wachstumsdifferenzierungsfaktor-12
ATE290315T1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
ATE374618T1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
DE69331813T4 (de) Verfahren zur Detektion und Behandlung von Individuen mit abnormal hla-a2/tyrosinase-peptidantigenen exprimierenden Zellen
DE69509673T2 (de) Peptide zur behandlung von allergien
DE69633393D1 (de) Mitteln zur behandlung von auto-immun krankheiten
IL128569A0 (en) Fibroblast growth factor homologous factor S(FHFs) and methods of use
EP0561877A4 (de)
DE69837265D1 (de) Polypeptide zur regenerierung des nervensystems
DE69526972D1 (de) Verwendung von Gabapentin in der Behandlung vonAngst - und Panikstörungen
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
BG105682A (en) Bone stimulating factor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee